Searching News Database: Teijin
HSMN NewsFeed - 1 Aug 2019
Neuronetics(R) Announces First TMS Patient Treated Under New Japan Reimbursement Policy
Neuronetics(R) Announces First TMS Patient Treated Under New Japan Reimbursement Policy
HSMN NewsFeed - 14 Feb 2018
SanBio and Teijin to Terminate Licensing Agreement regarding SB623 for Stroke Treatment
SanBio and Teijin to Terminate Licensing Agreement regarding SB623 for Stroke Treatment
HSMN NewsFeed - 26 Oct 2017
Teijin Nakashima Medical to Acquire Spinal-related Business of Century Medical
Teijin Nakashima Medical to Acquire Spinal-related Business of Century Medical
HSMN NewsFeed - 28 Apr 2017
Teijin to Withdraw from U.S. Home Health Care Business to Complete Business Restructuring
Teijin to Withdraw from U.S. Home Health Care Business to Complete Business Restructuring
HSMN NewsFeed - 14 Feb 2009
FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout
FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout
HSMN NewsFeed - 10 Jun 2008
Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
HSMN NewsFeed - 5 May 2008
Ipsen: Adenuric(R) (Febuxostat) Receives Marketing Authorisation in the European Union
Ipsen: Adenuric(R) (Febuxostat) Receives Marketing Authorisation in the European Union
HSMN NewsFeed - 31 Aug 2007
Ipsen: Somatuline(R) Depot Receives Marketing Approval in the United States for the Treatment of Acromegaly
Ipsen: Somatuline(R) Depot Receives Marketing Approval in the United States for the Treatment of Acromegaly
HSMN NewsFeed - 23 Oct 2006
ALTANA Pharma Receives Approval to Market Ciclesonide Nasal Spray in The U.S.
ALTANA Pharma Receives Approval to Market Ciclesonide Nasal Spray in The U.S.
HSMN NewsFeed - 2 Oct 2006
Ipsen: EMEA's Validation of Febuxostat's Marketing Authorization Application in the European Union
Ipsen: EMEA's Validation of Febuxostat's Marketing Authorization Application in the European Union
Additional items found! 4
Members Archive contains
4 additional stories matching:
Teijin
(Password required)
Teijin
(Password required)